• Profile
Close

Type 2 deiodinase Thr92Ala polymorphism is associated with a reduction in bone mineral density: A Community‐based Korean Genome and Epidemiology Study

Clinical Endocrinology Apr 29, 2020

Kang YE, Kang YM, Park B, et al. - Given that type 2 deiodinase (DIO2)‐mediated thyroid hormone synthesis stimulates osteoblast activity and increases the expression of osteoblast differentiation markers, researchers conducted this large cohort studies to identify the role of the DIO2 polymorphism in bone mineral density in humans. They evaluated the polymorphism of the DIO2 gene in 7,524 Koreans drawn from the large‐scale Ansan‐Anseong cohort of the Korean Genome and Epidemiology Study in order to examine the assumption that people with the DIO2 gene polymorphism are susceptible to osteoporosis. In total, 6,022 candidates [1,991 (33.0%) were homozygous for the Thr allele, 2,967 (49.3%) were heterozygous (Thr/Ala), and 1,064 (17.7%) were homozygous for the Ala allele] were involved. DIO2 Thr92Ala polymorphism is linked to decreased SOS and T‐scores in the tibia of female patients independent of other clinical parameters, where this suggests a possible functional involvement of DIO2 in BMD maintenance.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay